Characteristics of clinical trials for non-small cell lung cancer therapeutic vaccines registered on ClinicalTrials.gov

BACKGROUND: Even after complete surgical treatment or chemotherapy, Non-Small Cell Lung Cancer (NSCLC) patients are also at substantial risk for recurrence and spread trend. Therapeutic cancer vaccination could increase the anti-tumor immune response and prevent tumor relapse. This study aimed to as...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Wenyue, Xu, Yangjie, Chen, Xiaohong, Jiang, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627174/
https://www.ncbi.nlm.nih.gov/pubmed/36341464
http://dx.doi.org/10.3389/fimmu.2022.936667

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627174/
https://www.ncbi.nlm.nih.gov/pubmed/36341464
http://dx.doi.org/10.3389/fimmu.2022.936667

Ejemplares similares